Insights

Market Expansion Diabeloop has successfully launched its automated insulin delivery device in several European countries, presenting a sales opportunity to further penetrate these markets and expand its reach across the continent.

Partnership Opportunities Strategic partnerships with major healthcare companies like Novo Nordisk and EOFlow provide Diabeloop with avenues to collaborate on innovative solutions, creating sales channels for joint products and services.

Financial Growth Securing $75.1M in Series C funding indicates investor confidence in Diabeloop's offerings, presenting an opportunity for sales professionals to leverage this financial backing to drive expansion and customer acquisition.

Educational Content The launch of 'Diabeloop Talks,' a TED Talks-inspired series, provides a platform for educating and engaging potential customers, enhancing brand awareness and sales opportunities through insightful content.

Global Expansion Partnerships with companies like SOOIL Development support Diabeloop's international expansion ambitions, offering sales professionals the chance to capitalize on growing beyond Europe and accessing new markets.

Diabeloop Tech Stack

Diabeloop uses 8 technology products and services including Facebook Pixel, Docker, Gerrit, and more. Explore Diabeloop's tech stack below.

  • Facebook Pixel
    Analytics
  • Docker
    Containerization
  • Gerrit
    Development
  • Google Drive
    Document Management Systems
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • scikit-learn
    Machine Learning
  • Nginx
    Web Servers

Media & News

Diabeloop's Email Address Formats

Diabeloop uses at least 2 format(s):
Diabeloop Email FormatsExamplePercentage
First.Last@diabeloop.frJohn.Doe@diabeloop.fr
84%
First@diabeloop.frJohn@diabeloop.fr
13%
First.Middle@diabeloop.frJohn.Michael@diabeloop.fr
1%
Last.First@diabeloop.frDoe.John@diabeloop.fr
1%
FirstLast@diabeloop.frJohnDoe@diabeloop.fr
1%

Frequently Asked Questions

Where is Diabeloop's headquarters located?

Minus sign iconPlus sign icon
Diabeloop's main headquarters is located at 17, Rue Félix Esclangon Grenoble, Auvergne-Rhône-Alpes 38000 FR. The company has employees across 2 continents, including EuropeNorth America.

What is Diabeloop's official website and social media links?

Minus sign iconPlus sign icon
Diabeloop's official website is diabeloop.com and has social profiles on LinkedIn.

How much revenue does Diabeloop generate?

Minus sign iconPlus sign icon
As of November 2024, Diabeloop's annual revenue reached $15M.

What is Diabeloop's NAICS code?

Minus sign iconPlus sign icon
Diabeloop's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Diabeloop have currently?

Minus sign iconPlus sign icon
As of November 2024, Diabeloop has approximately 107 employees across 2 continents, including EuropeNorth America. Key team members include Chief Commercial Officer: C. F. G.Head Of Therapy Development: C. B.Chairman & Chief Executive Officer: F. M.. Explore Diabeloop's employee directory with LeadIQ.

What industry does Diabeloop belong to?

Minus sign iconPlus sign icon
Diabeloop operates in the Medical Equipment Manufacturing industry.

What technology does Diabeloop use?

Minus sign iconPlus sign icon
Diabeloop's tech stack includes Facebook PixelDockerGerritGoogle DrivejQuery MigratejQueryscikit-learnNginx.

What is Diabeloop's email format?

Minus sign iconPlus sign icon
Diabeloop's email format typically follows the pattern of . Find more Diabeloop email formats with LeadIQ.

How much funding has Diabeloop raised to date?

Minus sign iconPlus sign icon
As of November 2024, Diabeloop has raised $16M in funding. The last funding round occurred on Mar 04, 2024 for $16M.

When was Diabeloop founded?

Minus sign iconPlus sign icon
Diabeloop was founded in 2015.
Diabeloop

Diabeloop

Medical Equipment ManufacturingAuvergne-Rhône-Alpes, France51-200 Employees

We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. 

This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people.

Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.

Section iconCompany Overview

Headquarters
17, Rue Félix Esclangon Grenoble, Auvergne-Rhône-Alpes 38000 FR
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $16M

    Diabeloop has raised a total of $16M of funding over 6 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $16M.

  • $10M$50M

    Diabeloop's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $16M

    Diabeloop has raised a total of $16M of funding over 6 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $16M.

  • $10M$50M

    Diabeloop's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.